CII
GMED icon

CR Intrinsic Investors’s Globus Medical GMED Stock Holding History

CR Intrinsic Investors’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-270,000
Closed -$7.18M – 80
2014
Q1 		$7.18M Buy
270,000
+20,000
+8% +$475K 0.27% 134
2013
Q4 		$5.04M Sell
250,000
-25,000
-9% -$464K 0.22% 159
2013
Q3 		$4.8M Sell
275,000
-358,375
-57% -$6.2M 0.15% 198
2013
Q2 		$10.7M Buy
+633,375
New +$9.77M 0.37% 104

Other funds holding GMED

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
CCM
Century Capital Management Boston, Massachusetts $581M AUM 29.61% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CR Intrinsic Investors's GMED Position: Q2 2014 in Review

CR Intrinsic Investors sold out of Globus Medical (GMED) in Q2 2014, closing a stake of 270,000 shares — an estimated $7.18M sold.

CR Intrinsic Investors first reported a position in GMED in Q2 2013 and held it in 4 quarters. The position peaked at $10.7M in Q2 2013. 175 funds tracked by Wall St. Rank hold GMED as of Q2 2014.

  • CR Intrinsic Investors reported no remaining Globus Medical position as of Q2 2014 after selling out during the quarter.
  • CR Intrinsic Investors sold 270,000 Globus Medical shares in Q2 2014, an estimated $7.18M.
  • CR Intrinsic Investors first reported a position in Globus Medical in Q2 2013 and held it in 4 quarters.
  • CR Intrinsic Investors's Globus Medical position peaked at $10.7M in Q2 2013.
  • 175 funds tracked by Wall St. Rank held Globus Medical as of Q2 2014.

Based on CR Intrinsic Investors's 13F filing for Q2 2014.